Want to join the conversation?
$ADS 2Q15 PR: Revenue was $1,500.6MM vs. $1,265.2MM in 2Q14. Operating income was $285.7MM vs. $282.5MM in 2Q14. Net income attributable to shareholders $131.3MM vs. $137.4MM in 2Q14. Diluted EPS was $2.11 vs. $2.19 in 2Q14. Operating expenses were $1,214.9MM vs. $982.7MM in 2Q14.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.